Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag The ProstACT Phase 3 trial for advanced prostate cancer has begun its treatment phase with the first patient dosed, showing no safety issues so far.

flag The ProstACT global Phase 3 trial has begun its randomized treatment expansion phase with the first patient dosed, building on prior results. flag The trial, evaluating an investigational treatment for advanced prostate cancer across multiple countries, plans to release Part 1 results in the coming months. flag Initial safety data show no adverse events, and the trial is progressing on schedule with full regulatory and ethical compliance. flag Results will be reviewed by an independent committee before public release.

11 Articles